ClinicalTrialsFinder

Metastasis Castration Resistant Prostate Cancer(mCRPC) Clinical Trials in Nanjing

1 recruitingNanjing, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors

Metastasis Castration Resistant Prostate Cancer(mCRPC)
Hansoh BioMedical R&D Company120 enrolled15 locationsNCT06001255